Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2013 3
2014 1
2017 1
2018 1
2020 3
2021 4
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Krejci D, Opalka P, Krejci J, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Bratova M, Cernovska M, Hrnciarik M, Coupkova H, Hurdalkova K, Barinova M, Koubkova L, Dolezal D, Safanda M, Pesek M, Svaton M. Krejci D, et al. Among authors: hrnciarik m. Anticancer Res. 2021 May;41(5):2597-2603. doi: 10.21873/anticanres.15039. Anticancer Res. 2021. PMID: 33952489
Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Skrickova J, Pesek M, Opalka P, Koubkova L, Zemanova M, Hrnciarik M, Blazek J, Svaton M, Krejci J, Coupkova H, Dolezal D, Tuzova T, Holubec L, Mahadevia P, Sandstrom K, Kunovszki P, Barinova M, Hurdalkova K, Fischer O, Cernovska M, Bratova M. Skrickova J, et al. Among authors: hrnciarik m. Anticancer Res. 2021 Nov;41(11):5625-5634. doi: 10.21873/anticanres.15378. Anticancer Res. 2021. PMID: 34732435
Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry.
Venclicek O, Skrickova J, Brat K, Fischer O, Havel L, Hrnciarik M, Marel M, Opalka P, Krakorova G, Rozsivalova D, Kultan J, Mullerova A, Zarnayova L, Smickova P, Vasakova M, Gyorfy Z, Jirousek M, Krejci D, Krejci J, Zuna P, Svaton M, Hrda K, Duba J, Alahakoon J, Svoboda M, Silar J. Venclicek O, et al. Among authors: hrnciarik m. Anticancer Res. 2021 Nov;41(11):5549-5556. doi: 10.21873/anticanres.15368. Anticancer Res. 2021. PMID: 34732425
[TARCEVA Clinical Registry].
Skricková J, Pesek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Krejcí J, Tomísková M, Grygárková Y, Havel L, Hrnciarik M, Skalová B, Stícha M. Skricková J, et al. Among authors: hrnciarik m. Klin Onkol. 2010;23(5):361-3. Klin Onkol. 2010. PMID: 21061685 Czech. No abstract available.
Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.
Marel M, Chladkova Z, Casas Mendez LF, Venclicek O, Skrickova J, Fischer O, Mullerova A, Havel L, Gyorfy Z, Hrnciarik M, Jirousek M, Krejci J, Krejci D, Buresova M, Alahakoon J, Svoboda M, Svaton M. Marel M, et al. Among authors: hrnciarik m. Cancer Diagn Progn. 2022 Mar 3;2(2):167-172. doi: 10.21873/cdp.10091. eCollection 2022 Mar-Apr. Cancer Diagn Progn. 2022. PMID: 35399169 Free PMC article.
Erlotinib in the treatment of advanced squamous cell NSCLC.
Fiala O, Pesek M, Finek J, Krejci J, Havel L, Hrnciarik M, Salajka F, Bortlicek Z, Benesova L, Minarik M. Fiala O, et al. Among authors: hrnciarik m. Neoplasma. 2013;60(6):676-82. doi: 10.4149/neo_2013_086. Neoplasma. 2013. PMID: 23906302
20 results